Immunotherapy
This presentation is the property of its rightful owner.
Sponsored Links
1 / 10

Immunotherapy PowerPoint PPT Presentation


  • 118 Views
  • Uploaded on
  • Presentation posted in: General

Immunotherapy. Personal statistics (updated, 2013) John Weisnagel, M.D. Database. Sept 1992-Dec 2012: 31,150 patients Undergoing immunotherapy: 2,533 pts (8%) Perennial Rx (all-year long): 1,490 (58.8%)

Download Presentation

Immunotherapy

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


Immunotherapy

Immunotherapy

Personal statistics

(updated, 2013)

John Weisnagel, M.D.


Database

Database

  • Sept 1992-Dec 2012: 31,150 patients

  • Undergoing immunotherapy: 2,533 pts (8%)

    • Perennial Rx (all-year long): 1,490 (58.8%)

    • Pre-seasonal Rx (one injection per week (for 4 or 9 weeks depending on type of Rx, 1-2 months preceding the specific pollen season): 1020 (40.2%)

      • 23 pts having rec’d both types of treatment.


Efficacy of immunotherapy

Efficacy of immunotherapy

  • Of the 2,533 treated since 1992,

  • 1046 replied to the question of the effect of their treatment (excellent, very good, good, slight or no change) when reminders were sent them about renewals

    • Treatment was:

      • Perennial in 596

      • Pre-seasonal in 450


Perennial treatment

Perennial Treatment

  • 596 patients:

    • Asthma: 53 (8.8%)

    • Asthma + pollinosis: 74 (12.4%)

    • Asthma + rhinitis: 86 (14.4%)

    • Pollinosis: 155 (26%)

    • Rhinitis: 225 (37.7%)


Efficacy of perennial treatment in 596 patients

Efficacy of Perennial treatment in 596 patients


Pre seasonal treatment

Pre-seasonal Treatment

  • 450 patients with pollen allergy, some with associated asthma:

    Reported effect:

    Excellent in 82 (18.2%)

    Very good in 135 (30%)

    Good in 111 (24.6%)

    Slight in 48 (10.6%)

    Ineffective in 24 (5.3%)


Efficacy summary

Efficacy summary

  • Perennial treatment averaged :

  • 18.5% for slight improvement

  • 28.9% for good “

  • 30.3% for very good “

  • 10.1% for excellent “

  • while ineffective in only 11.8%

  • Pre-seasonal treatment averaged:

  • 10.6% for slight improvement

  • 24.6% for good “

  • 30% for very good “

    • 18.2% for excellent “

    • while ineffective in only 5.3%


Pre seasonals

Pre-seasonals

  • Center-Al™

  • Suspal™

  • Pollinex R™

    • Other tyrosine preps.


Perennials

Perennials

  • Mixtures:

    • House dust mite + pollens

    • House dust mite + molds

    • House dust mite + pollens + molds


Bottom line

Bottom line

  • These personal statistics, though anecdotal, reflect the conclusion of the many studies published on the benefit of immunotherapy.

  • Both forms of therapy, perennial and pre-seasonal have similar benefits.

  • Immunotherapy is still an effective treatment in respiratory allergy, and should be considered when pharmaceutical therapy is inadequate.


  • Login